{"entity":{"type":"insider","cik":"0001472129","url":"/insider/0001472129","json_url":"/insider/0001472129.json","name":"Petteway Stephen R Jr","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2010-09-03","last":"2011-02-02","span_basis":"filed_date"},"name_variants":[{"name":"Petteway Stephen R Jr","source":"filing","n_filings":6,"first_seen":"2010-09-03","last_seen":"2011-02-02"}],"transactions":[{"id":9056489,"accession":"0001225208-11-004558","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-11-004558","line_url":"/filing/0001225208-11-004558#line-2","is_derivative":false,"issuer_cik":"0001405197","issuer_name":"Talecris Biotherapeutics Holdings Corp.","issuer_ticker":"TLCR","issuer_name_source":null,"issuer_url":"/issuer/0001405197","owner_cik":"0001472129","owner_name":"Petteway Stephen R Jr","owner_display_name":"Petteway Stephen R Jr","owner_url":"/insider/0001472129","role":"Officer (Executive VP, R&D)","role_mark":"O","role_mark_label":"Officer (Executive VP, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":24.3684,"price_display":"24.37","price_state":"stated","total_value":609210.0,"total_display":"609,210.00","total_whole":"609,210","shares_owned_after":40198.0,"shares_owned_after_display":"40,198","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-01","filed_date":"2011-02-02","scope":"insider"},{"id":9082407,"accession":"0001225208-11-000649","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-11-000649","line_url":"/filing/0001225208-11-000649#line-2","is_derivative":false,"issuer_cik":"0001405197","issuer_name":"Talecris Biotherapeutics Holdings Corp.","issuer_ticker":"TLCR","issuer_name_source":null,"issuer_url":"/issuer/0001405197","owner_cik":"0001472129","owner_name":"Petteway Stephen R Jr","owner_display_name":"Petteway Stephen R Jr","owner_url":"/insider/0001472129","role":"Officer (Executive VP, R&D)","role_mark":"O","role_mark_label":"Officer (Executive VP, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":23.0638,"price_display":"23.06","price_state":"stated","total_value":576595.0,"total_display":"576,595.00","total_whole":"576,595","shares_owned_after":45198.0,"shares_owned_after_display":"45,198","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-01-03","filed_date":"2011-01-04","scope":"insider"},{"id":7326025,"accession":"0001225208-10-026172","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-10-026172","line_url":"/filing/0001225208-10-026172#line-2","is_derivative":false,"issuer_cik":"0001405197","issuer_name":"Talecris Biotherapeutics Holdings Corp.","issuer_ticker":"TLCR","issuer_name_source":null,"issuer_url":"/issuer/0001405197","owner_cik":"0001472129","owner_name":"Petteway Stephen R Jr","owner_display_name":"Petteway Stephen R Jr","owner_url":"/insider/0001472129","role":"Officer (Executive VP, R&D)","role_mark":"O","role_mark_label":"Officer (Executive VP, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":21.5,"price_display":"21.50","price_state":"stated","total_value":537500.0,"total_display":"537,500.00","total_whole":"537,500","shares_owned_after":50198.0,"shares_owned_after_display":"50,198","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-01","filed_date":"2010-12-02","scope":"insider"},{"id":7354174,"accession":"0001225208-10-024003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-10-024003","line_url":"/filing/0001225208-10-024003#line-2","is_derivative":false,"issuer_cik":"0001405197","issuer_name":"Talecris Biotherapeutics Holdings Corp.","issuer_ticker":"TLCR","issuer_name_source":null,"issuer_url":"/issuer/0001405197","owner_cik":"0001472129","owner_name":"Petteway Stephen R Jr","owner_display_name":"Petteway Stephen R Jr","owner_url":"/insider/0001472129","role":"Officer (Executive VP, R&D)","role_mark":"O","role_mark_label":"Officer (Executive VP, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":24.3703,"price_display":"24.37","price_state":"stated","total_value":609257.5,"total_display":"609,257.50","total_whole":"609,258","shares_owned_after":55198.0,"shares_owned_after_display":"55,198","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-11-01","filed_date":"2010-11-02","scope":"insider"},{"id":7184937,"accession":"0001225208-10-021987","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-10-021987","line_url":"/filing/0001225208-10-021987#line-2","is_derivative":false,"issuer_cik":"0001405197","issuer_name":"Talecris Biotherapeutics Holdings Corp.","issuer_ticker":"TLCR","issuer_name_source":null,"issuer_url":"/issuer/0001405197","owner_cik":"0001472129","owner_name":"Petteway Stephen R Jr","owner_display_name":"Petteway Stephen R Jr","owner_url":"/insider/0001472129","role":"Officer (Executive VP, R&D)","role_mark":"O","role_mark_label":"Officer (Executive VP, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":22.806,"price_display":"22.81","price_state":"stated","total_value":570150.0,"total_display":"570,150.00","total_whole":"570,150","shares_owned_after":60198.0,"shares_owned_after_display":"60,198","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-10-01","filed_date":"2010-10-04","scope":"insider"},{"id":7746630,"accession":"0001225208-10-020376","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-10-020376","line_url":"/filing/0001225208-10-020376#line-2","is_derivative":false,"issuer_cik":"0001405197","issuer_name":"Talecris Biotherapeutics Holdings Corp.","issuer_ticker":"TLCR","issuer_name_source":null,"issuer_url":"/issuer/0001405197","owner_cik":"0001472129","owner_name":"Petteway Stephen R Jr","owner_display_name":"Petteway Stephen R Jr","owner_url":"/insider/0001472129","role":"Officer (Executive VP, R&D)","role_mark":"O","role_mark_label":"Officer (Executive VP, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":21.9925,"price_display":"21.99","price_state":"stated","total_value":549812.5,"total_display":"549,812.50","total_whole":"549,813","shares_owned_after":65198.0,"shares_owned_after_display":"65,198","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-09-01","filed_date":"2010-09-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001405197","name":"Talecris Biotherapeutics Holdings Corp.","url":"/issuer/0001405197","role":"Officer (Executive VP, R&D)","n_filings":6,"first_seen":"2010-09-03","last_seen":"2011-02-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001472129","retrieved_at":"2026-08-22T08:54:47+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}